Juhan-Vague I - Search Results

1

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis.

Juhan-Vague I, Alessi MC, Vague P. Juhan-Vague I, et al. Diabetologia. 1991 Jul;34(7):457-62. doi: 10.1007/BF00403280. Diabetologia. 1991. PMID: 1916049 Review.

2

The insulin resistance syndrome: implications for thrombosis and cardiovascular disease.

Juhan-Vague I, Morange PE, Alessi MC. Juhan-Vague I, et al. Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):269-73. doi: 10.1159/000073579. Pathophysiol Haemost Thromb. 2002. PMID: 13679655 Review.

3

[The link between molecules produced by the adipose tissue, obesity and atherothrombosis].

Alessi MC, Frère C, Juhan-Vague I. Alessi MC, et al. Presse Med. 2005 Jun 18;34(11):820-4. doi: 10.1016/s0755-4982(05)84051-5. Presse Med. 2005. PMID: 16097387 Review. French.

4

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.

Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, Declerck PJ, Serradimigni A, Collen D. Juhan-Vague I, et al. Arteriosclerosis. 1989 May-Jun;9(3):362-7. doi: 10.1161/01.atv.9.3.362. Arteriosclerosis. 1989. PMID: 2470343

5

Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women.

Vague P, Juhan-Vague I, Chabert V, Alessi MC, Atlan C. Vague P, et al. Metabolism. 1989 Sep;38(9):913-5. doi: 10.1016/0026-0495(89)90241-2. Metabolism. 1989. PMID: 2505018

6

Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin.

Juhan-Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P. Juhan-Vague I, et al. Thromb Haemost. 1989 Jun 30;61(3):370-3. Thromb Haemost. 1989. PMID: 2678583

7

Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.

Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C. Juhan-Vague I, et al. Diabete Metab. 1987 Jul;13(3 Pt 2):331-6. Diabete Metab. 1987. PMID: 3115843 Clinical Trial.

8

Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2.

Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D. Alessi MC, et al. Thromb Haemost. 1988 Dec 22;60(3):491-4. Thromb Haemost. 1988. PMID: 3149048

9

Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects.

Vague P, Juhan-Vague I, Alessi MC, Badier C, Valadier J. Vague P, et al. Thromb Haemost. 1987 Jun 3;57(3):326-8. Thromb Haemost. 1987. PMID: 3310318 Clinical Trial.

10

Up-regulated expression of plasminogen activator inhibitor-1 in Hep G2 cells: interrelationship between insulin and insulin-like growth factor 1.

Anfosso F, Alessi MC, Nalbone G, Chomiki N, Henry M, Juhan-Vague I. Anfosso F, et al. Thromb Haemost. 1995 Feb;73(2):268-74. Thromb Haemost. 1995. PMID: 7792742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters